SOP for IVD investigational products – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Wed, 01 Oct 2025 09:37:33 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for IVD Trial Sample Handling and Reporting https://www.clinicalstudies.in/sop-for-ivd-trial-sample-handling-and-reporting/ Wed, 01 Oct 2025 09:37:33 +0000 ]]> https://www.clinicalstudies.in/?p=7049 Read More “SOP for IVD Trial Sample Handling and Reporting” »

]]>
SOP for IVD Trial Sample Handling and Reporting

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-ivd-trial-sample-handling-and-reporting”
},
“headline”: “SOP for IVD Trial Sample Handling and Reporting”,
“description”: “This SOP defines standardized procedures for handling and reporting samples in in vitro diagnostic (IVD) clinical trials, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements. It covers collection, processing, shipment, chain of custody, result reporting, and quality oversight.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for IVD Trial Sample Handling and Reporting

SOP No. CR/OPS/109/2025
Supersedes NA
Page No. 1 of 47
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to establish standardized procedures for handling and reporting samples in in vitro diagnostic (IVD) clinical trials. Proper sample handling and accurate reporting ensure subject safety, data integrity, regulatory compliance, and validity of trial outcomes.

Scope

This SOP applies to all sponsors, CROs, investigators, laboratories, and site staff involved in IVD clinical trials. It covers sample collection, labeling, processing, storage, shipment, chain of custody, laboratory testing, result reporting, and archiving of records.

Responsibilities

  • Sponsor: Oversees IVD trial sample handling and ensures compliance with global regulations.
  • Investigator/Site Staff: Responsible for accurate sample collection, labeling, and shipment.
  • Laboratories: Perform sample analysis and maintain reporting accuracy.
  • CRO: Monitors compliance with sample handling SOPs across sites.
  • QA: Audits sample handling and reporting processes for accuracy and GCP compliance.

Accountability

The Investigator is accountable for site-level IVD sample handling and reporting. The Sponsor is accountable for ensuring oversight, data quality, and regulatory submission compliance.

Procedure

1. Sample Collection
1.1 Collect samples per study protocol and informed consent requirements.
1.2 Label each sample with subject ID, date, time, and trial identifier.
1.3 Record in Sample Collection Log (Annexure-1).

2. Sample Processing
2.1 Process samples as per laboratory manual (centrifugation, aliquoting, stabilization).
2.2 Document processing steps in Sample Processing Log (Annexure-2).

3. Sample Storage
3.1 Store samples under specified conditions (temperature, humidity, light protection).
3.2 Maintain storage records in Sample Storage Log (Annexure-3).

4. Sample Shipment
4.1 Ship samples using validated containers and cold-chain management.
4.2 Document shipment details in Sample Shipment Log (Annexure-4).

5. Chain of Custody
5.1 Maintain custody records from collection through analysis.
5.2 Ensure only authorized personnel handle samples.
5.3 Record in Chain of Custody Log (Annexure-5).

6. Result Reporting
6.1 Laboratories generate validated results and transmit securely to sponsor.
6.2 Record results in Result Reporting Log (Annexure-6).
6.3 Address discrepancies in reporting promptly.

7. Archiving
7.1 Archive sample records, logs, and test results in TMF and ISF.
7.2 Retain records per regulatory requirements.

Abbreviations

  • SOP: Standard Operating Procedure
  • IVD: In Vitro Diagnostic
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • TMF: Trial Master File
  • ISF: Investigator Site File
  • FDA: Food and Drug Administration
  • EMA: European Medicines Agency
  • CDSCO: Central Drugs Standard Control Organization
  • WHO: World Health Organization

Documents

  1. Sample Collection Log (Annexure-1)
  2. Sample Processing Log (Annexure-2)
  3. Sample Storage Log (Annexure-3)
  4. Sample Shipment Log (Annexure-4)
  5. Chain of Custody Log (Annexure-5)
  6. Result Reporting Log (Annexure-6)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Clinical Laboratory Specialist
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Sample Collection Log

Date Subject ID Sample Type Collected By Status
01/09/2025 S101 Blood Study Nurse Collected

Annexure-2: Sample Processing Log

Date Sample ID Processing Activity Performed By Status
01/09/2025 S101-B1 Centrifuged Lab Technician Completed

Annexure-3: Sample Storage Log

Date Sample ID Storage Temp Stored By Remarks
02/09/2025 S101-B1 -20°C Lab Assistant Stable

Annexure-4: Sample Shipment Log

Date Sample ID Shipment Method Shipped By Status
03/09/2025 S101-B1 Cold Chain Courier Site Coordinator In Transit

Annexure-5: Chain of Custody Log

Date Sample ID Transferred From Transferred To Signature
03/09/2025 S101-B1 Site Coordinator Courier Signed

Annexure-6: Result Reporting Log

Date Sample ID Reported By Result Status
05/09/2025 S101-B1 Lab Analyst Negative Reported

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Operations

For more SOPs visit: Pharma SOP

]]>